Alexion Pharma

Wilson Therapeutics is a biopharmaceutical company based in Stockholm, Sweden, that develops novel therapies for rare diseases. The company is listed in the Mid Cap segment on Nasdaq Stockholm with the stock ticker WTX. As of 2016, tetrathiomolybdate had been tested in over 500 patients for up to seven years, primarily in oncology and Wilson's disease, as well as some other clinical pathologies.

Wilson Therapeutics

Synageva was a publicly listed biopharmaceutical company headquartered in Lexington, Massachusetts dedicated to discovering, developing and delivering medicines for patients with rare diseases and high unmet medical needs. The company had manufacturing and laboratory locations in Lexington and Holden, Massachusetts, Bogart and Athens Georgia, as well as offices in a variety of locations around the world.

Synageva

Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer, and autoimmune disorders. Its marketed product Soliris (eculizumab) is a therapy approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH).  In April 2009 and August 2009, the United States food and drug administration (FDA) and the European Commission (E.C.), respectively, granted Soliris orphan drug designation for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS). In December 2009, its Rhode Island manufacturing facility received regulatory approval from the E.C. Or the production of Soliris.

Horizon Pharma

ALXN vs. HZNP: Which Stock Is the Better Value Option?

ALXN vs. HZNP: Which Stock Should Value Investors Buy Now?

Constellium NV Class A

Sunrun

With 2019 fading fast and 2020 rapidly approaching, investors are having to reflect on where the markets started out this year and where they are likely going in in the year ahead.

Credit Suisse Has 3 Top Picks for 50% or More Implied Upside in 2020

ACADIA Pharma

Anika Therapeutics

Gilead Sciences

Incyte

Regeneron Pharmaceuticals

Vertex Pharmaceuticals

Biotech Stock Outlook: M&A Activity Retains Growth Streak

Both of these drugmakers have solid portfolios and treatment pipelines, but savvy investors will find good reason to favor one over the other.

Better Buy:  Vertex Pharmaceuticals vs.  Alexion Pharmaceuticals

Changyou.com Ltd.

Jazz Pharmaceuticals

Legg Mason

Navient

Quanta Services

P/B ratio is emerging as a convenient tool for identifying low-priced stocks with high-growth prospects.

6 Low Price-to-Book Value Stocks to Buy in December

Alexion (ALXN) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Alexion (ALXN) Looks Good: Stock Adds 6% in Session

Alexion Pharmaceuticals decided against selling itself, the biotech company said in a news release on Friday — prodding ALXN stock to jump. An activist investor suggested it launch a sale.

An Activist Investor Pushed This Biotech To Sell — Why It Refused

Shares of Alexion Pharmaceuticals ALXN, +2.36% are up 6% in morning trading after the company halted its stock in premarket trading to announce that it would not consider a sale, as recommended by Elliott Management.

Alexion stocks rises on decision not to consider a sale

AXA Equitable Holdings Inc

Seaspan

Tenet Healthcare

Although PEG is categorized under value investing, it follows the principles of both growth and value investing.

5 Discounted PEG Stocks for GARP Investors

Civeo

Integer Holdings

OpGen

ReWalk Robotics

What bargain hunting? Stocks with a rising P/E can also be worth buying too.

Adopt Rising P/E Technique With These 5 Top-Ranked Stocks

Illumina

ALXN vs. ILMN: Which Stock Is the Better Value Option?

Biogen

BioMarin Pharmaceutical

Here are four stocks that boast promising prospects and are most likely to be takeout targets.

4 Big Drug Stocks Ripe for Takeover After NVS-MDCO Deal

Alexion (ALXN) gets Japan Ministry of Health, Labour and Welfare's approval for the label expansion of Soliris.

Alexion Gets Approval for Label Expansion of Soliris in Japan

Alexion (ALXN) reported earnings 30 days ago. What's next for the stock?

Alexion (ALXN) Up 3.3% Since Last Earnings Report: Can It Continue?

We highlight a few principal players from the biotech sector, which are likely to witness a winning run in the near term.

4 Big Biotech Stocks Worth Considering Post Q3 Earnings

Cambrex

ALXN vs. CBM: Which Stock Is the Better Value Option?

ALXN vs. CBM: Which Stock Should Value Investors Buy Now?

Avinger

CyberArk Software

Organovo Hlds

Qualys

Bet on these top-ranked stocks with rising P/E for outsized gains.

What Bargain Hunting ? Tap 5 Stocks With Rising P/E

Alexion's (ALXN) stock rises 10% in the year so far as Soliris maintains momentum and Ultomiris gains further traction.

Alexion (ALXN) Up 10 % YTD on Soliris & Ultomiris Strength

AMETEK

IQVIA Hlds

Lowe's

Thermo Fisher Scientific

Given the bullishness and record-high market, we have screened for five S&P 500 stocks that are most loved by the brokerage firms.

5 Most-Loved S&P 500 Stocks on Wall Street

Celgene

Gildan Activewear

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside.

Major Biotechs See Rising Tide in Short Interest (Nov 12)

McDonald's

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

These 3 big stock charts, including MCD stock, highlight S&P 500 components set up for big potential moves.
The post 3 Big Stock Charts for Tuesday: Verizon, McDonald’s, and Alexion Pharmaceuticals appeared first on InvestorPlace.

3 Big Stock Charts for Tuesday: Verizon, McDonald’s, and Alexion Pharmaceuticals

ALXN or CBM: Which Is the Better Value Stock Right Now?

Check Point Software Technologies

ServiceNow

TripAdvisor

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

Try Rising P/E Investing With 5 Top-Ranked Stocks

Amgen

MannKind

The short interest data are out for the most recent settlement date, October 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside.

Major Biotechs See Rising Tide in Short Interest (Oct 25)

Edwards Lifesciences

These health-related businesses managed to surprise themselves.

News for Alexion Pharma Stock (ALXN)